Front-line Treatment of BCR-ABL+ Chronic Myeloid Leukemia (CML) With Dasatinib
Clinical trial NCT01761890 · UNKNOWN
Trial details
- NCT number
- NCT01761890
- Sponsor
- Gruppo Italiano Malattie EMatologiche dell'Adulto
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2014-01-28
- Primary completion
- 2018-12-02
- Enrollment
- 147
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.